FIVE PRIME THERAPEUTICS INC 4
4 · FIVE PRIME THERAPEUTICS INC · Filed May 23, 2016
Insider Transaction Report
Form 4
Douglas R Lee
Director
Transactions
- Award
Stock Option (right to buy)
2016-05-19+10,000→ 0 totalExercise: $42.25Exp: 2026-05-19→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option will vest in its entirety on the earlier to occur of (i) May 19, 2017 or (ii) the day before the 2017 annual meeting of stockholders of Five Prime Therapeutics, Inc.